Tenax Therapeutics Statistics
NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.91-0.02 (-1.04%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.93 +0.93%
Tenax Therapeutics by the numbers
Tenax Therapeutics has a market capitalization of $71.5 million based on 37.42M shares outstanding. With trailing EPS of $-1.48, Tenax Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.9% below its 50-day average and 82.7% below its 200-day average.
Average daily trading volume is 5.44M shares, or about $10.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TENX valuation vs. peer median
| Metric | TENX | Peer median | Difference |
|---|---|---|---|
| Market cap | $71.48M | $72.70M | -2% |
| Avg. volume | 5.44M | 361.37K | +1406% |
Peer median across 8 companies: OSTX, MAIA, GANX, HRTX, VRCA, CING, HYFT, LFVN.
Valuation
- Market cap
- $71.48M
- EPS (TTM)
- $-1.48
- Shares outstanding
- 37.42M
Price and trading
- Previous close
- 1.93
- Open
- 1.92
- Day range
- 1.89 – 1.95
- 52-week range
- 1.31 – 19.40
- 52-week change
- -74.50%
- Beta
- —
- Volume
- 697.89K
- Average volume
- 5.44M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 71.48M
- Forward Pe
- -1.27
- Eps
- -1.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.40
- Week52 Low
- 1.31
- Avg Volume
- 5.44M
- Shares Outstanding
- 37.42M
- Ma50
- 3.81
- Ma200
- 11.04
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -90.15%
- Pct From52w Low
- 45.80%